Sign In
Buy HR
$21.01
-0.520 (-2.42%)
At Close: Jul 31, 2026
Healthcare Realty Trust Q2 Earnings Call Highlights
03:06pm, Friday, 31'st Jul 2026
Healthcare Realty Trust NYSE: HR reported second-quarter results marked by higher occupancy, leasing activity, same-store net operating income growth and an increase to its full-year funds-from-operat
Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript
02:03pm, Friday, 31'st Jul 2026
Healthcare Realty Trust Incorporated (HR) Q2 2026 Earnings Call Transcript
Healthcare Realty Trust (HR) Q2 FFO and Revenues Beat Estimates
07:00pm, Thursday, 30'th Jul 2026
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to FFO of $0.41 per share a y
Healthcare Realty Reports Second Quarter 2026 Results and Further Increases Full Year 2026 Guidance
04:01pm, Thursday, 30'th Jul 2026
NASHVILLE, Tenn., July 30, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2026. In addition, the Company announce
Healthcare Realty Trust Announces Second Quarter Earnings Release Date and Conference Call
07:00am, Tuesday, 07'th Jul 2026
NASHVILLE, Tenn., July 07, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) today announced that on Thursday, July 30, 2026, after the market closes, it is scheduled to report r
enGene Reports Second Quarter 2026 Financial Results and Provides Business Update
10:00am, Monday, 15'th Jun 2026
enGene Therapeutics Inc. (Nasdaq: ENGN, âenGeneâ or the âCompanyâ), a clinical-stage, non-viral genetic medicines company today announced its financial
New Strong Buy Stocks for June 8th
07:36am, Monday, 08'th Jun 2026
EXPD, VNCE, UCTT, PRG and TNET have been added to the Zacks Rank #1 (Strong Buy) List on June 8, 2026.
Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a cyclin-dependent kinase (CDK) 4/6 inhibitor â palbociclib
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from the Phase III HARMONi-6 trial, conducted in China and spons
[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ
Healthcare Realty Trust: Betting On Outpatient Demand Growth, Lower Operator Risk (Upgrade)
12:56pm, Tuesday, 19'th May 2026
Healthcare Realty Trust is well positioned in the outpatient medical REIT space, benefiting from macro trends like aging demographics and rising outpatient care demand. HR's growth is supported by a n
AstraZeneca and Daiichi Sankyo's ENHERTUÂ (fam-trastuzumab deruxtecan-nxki) has been approved by the US Food and Drug Administration (FDA) for both the neoadj
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
12:03pm, Friday, 15'th May 2026
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
D2L Survey Reveals How AI is Beginning to Reshape Entry-Level Work and the Talent Pipeline
11:00am, Tuesday, 12'th May 2026
D2L Survey Reveals How AI is Beginning to Reshape Entry-Level Work and the Talent Pipeline PR Newswire TORONTO,
Healthcare Realty Announces Pricing of Upsized $600 Million Exchangeable Senior Notes Offering
06:40am, Tuesday, 05'th May 2026
NASHVILLE, Tenn., May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE: HR) (“Healthcare Realty”) today announced that its operating partnership, Healthcare Realty Holdings,
